RIGI and nasopharyngeal carcinoma: To further study the effects of RIG‐I on paclitaxel resistance in NPC cells, we knocked down RIG‐I in the CNE1 and CNE2 cell lines(Figure S2C,D) and evaluated the effects using MTT assays, flow cytometry analysis, and Western blotting.